Intravascular Lithotripsy Market Size & Share, by Application Type (Coronary Artery Disease, Kidney Disorder, Facilitated Vascular Access, Peripheral Arterial Disease); End User (Hospitals, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2036

  • Report ID: 5366
  • Published Date: Nov 03, 2023
  • Report Format: PDF, PPT

Companies Dominating the Intravascular Lithotripsy Landscape

top-features-companies
    • Shockwave Medical Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AVS
    • Cardiovascular Systems, Inc.
    • Abbott Laboratories
    • Siemens AG
    • Olympus America
    • Boston Scientific
    • Medispec Ltd
    • Dornier MedTech GmbH
    • Elmed Electronics & Medical Industry & Trade Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • AVS announced the closing of $8.8 million in new funding, bringing its Series B funding round to $28.8 million. The funding will continue to support clinical trials of the company's pulsed intravascular lithotripsy (PIVL) device in peripheral settings, while also advancing preclinical research to expand indications in coronary cases. In September 2022, AVS successfully enrolled, processed and collected favorable 30-day follow-up data from patients in the first-in-human POWER PAD I clinical trial. Prospective, multicenter, single-arm feasibility study evaluated the technical and clinical effectiveness of the PULSETM IVL System in the treatment of patients with femoral popliteal artery calcification.
  • Shockwave Medical, Inc. announced full commercial product availability in the United States for the Shockwave L6 peripheral IVL catheter following FDA clearance. The Shockwave L6 catheter is specifically designed to correct calcification of refractory lesions in large peripheral vessels, including the common iliac and femoral arteries. Calcification of these arteries is common and is associated with decreased procedural success and increased complications with standard intravascular techniques.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5366
  • Published Date: Nov 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of cardiovascular disease and increasing research and development in intravascular lithotripsy are some of the major factors anticipated to drive the growth of the intravascular lithotripsy market.

The market is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2024-2036.

The major players in the market are of Abbott Laboratories, Siemens AG, Olympus America, Boston Scientific, Medispec Ltd, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc., and others.

The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying